ArticleAmerican journal of cancer research2016

BRAF kinase inhibitor exerts anti-tumor activity against breast cancer cells via inhibition of FGFR2.

Zong Xin Zhang et al.PubMed ↗Full text ↗

No numbers read from the abstract.